106 related articles for article (PubMed ID: 12097435)
1. Salivary defense factors in herpes simplex virus infection.
Välimaa H; Waris M; Hukkanen V; Blankenvoorde MF; Nieuw Amerongen AV; Tenovuo J
J Dent Res; 2002 Jun; 81(6):416-21. PubMed ID: 12097435
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus reactivation as a trigger of mucous lesions in pemphigus vulgaris.
Kurata M; Mizukawa Y; Aoyama Y; Shiohara T
Br J Dermatol; 2014 Sep; 171(3):554-60. PubMed ID: 24660994
[TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients.
da Silva LM; Guimarães AL; Victória JM; Gomes CC; Gomez RS
Oral Dis; 2005 Jan; 11(1):13-6. PubMed ID: 15641961
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic Reactivation of HSV Infection Correlates with Decreased Serum Levels of TNF-α.
Motamedifar M; Sarvari J; Ebrahimpour A; Emami A
Iran J Immunol; 2015 Mar; 12(1):27-34. PubMed ID: 25784095
[TBL] [Abstract][Full Text] [Related]
5. Intimate male partner violence impairs immune control over herpes simplex virus type 1 in physically and psychologically abused women.
Garcia-Linares MI; Sanchez-Lorente S; Coe CL; Martinez M
Psychosom Med; 2004; 66(6):965-72. PubMed ID: 15564366
[TBL] [Abstract][Full Text] [Related]
6. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
7. An assay method for herpes simplex virus type 1 seroprevalence survey--detection of antibody in saliva by avidin-biotin complex enzyme-linked immunosorbent assay (ABC-ELISA).
Zhang ZQ
Microbiol Immunol; 1993; 37(10):773-7. PubMed ID: 8289684
[TBL] [Abstract][Full Text] [Related]
8. HSV-1 DNA in tears and saliva of normal adults.
Kaufman HE; Azcuy AM; Varnell ED; Sloop GD; Thompson HW; Hill JM
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):241-7. PubMed ID: 15623779
[TBL] [Abstract][Full Text] [Related]
9. Salivary neutralizing activity against herpes simplex virus type 1.
Gyselink R; Coles D; Ash RJ; Fritz ME
J Infect Dis; 1978 May; 137(5):583-6. PubMed ID: 207786
[TBL] [Abstract][Full Text] [Related]
10. Recovery of immune control over herpes simplex virus type 1 in female victims of intimate partner violence.
Sanchez-Lorente S; Blasco-Ros C; Coe CL; Martinez M
Psychosom Med; 2010 Jan; 72(1):97-106. PubMed ID: 19933506
[TBL] [Abstract][Full Text] [Related]
11. Distribution of HSV-1 IgG antibodies by two methods comparing in Turkish atopic children.
Artiran Igde F; Igde M; Yazici Z; Okur Gumusova S; Birinci A; Sancak R; Ozturk F
New Microbiol; 2007 Apr; 30(2):109-12. PubMed ID: 17619253
[TBL] [Abstract][Full Text] [Related]
12. The impact of dental surgery on HSV-1 reactivation in the oral mucosa of seropositive patients.
Marques-Silva L; Castro WH; Gomez EL; Guimarães AL; Silva MS; Gomez RS
J Oral Maxillofac Surg; 2007 Nov; 65(11):2269-72. PubMed ID: 17954324
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences.
McKenna DB; Neill WA; Norval M
Br J Dermatol; 2001 Mar; 144(3):459-64. PubMed ID: 11259999
[TBL] [Abstract][Full Text] [Related]
14. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera.
Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS
Virol J; 2016 Mar; 13():44. PubMed ID: 26987753
[TBL] [Abstract][Full Text] [Related]
15. Comparison of several ELISA tests for detecting the presence of IgG and IgM against herpes simplex viruses.
Gutiérrez J; Fernández F; Vergara MJ; Suárez S; Soto MJ; Maroto MC
Microbios; 2000; 103(405):127-32. PubMed ID: 11092194
[TBL] [Abstract][Full Text] [Related]
16. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.
Morrow R; Friedrich D
Clin Microbiol Infect; 2006 May; 12(5):463-9. PubMed ID: 16643524
[TBL] [Abstract][Full Text] [Related]
17. The herpes-specific immune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labialis.
Brice SL; Stockert SS; Bunker JD; Bloomfield D; Huff JC; Norris DA; Weston WL
Arch Dermatol Res; 1993; 285(4):193-6. PubMed ID: 8342962
[TBL] [Abstract][Full Text] [Related]
18. Association between herpes simplex virus-1 infection and idiopathic unilateral facial paralysis in children and adolescents.
Khine H; Mayers M; Avner JR; Fox A; Herold B; Goldman DL
Pediatr Infect Dis J; 2008 May; 27(5):468-9. PubMed ID: 18360300
[TBL] [Abstract][Full Text] [Related]
19. Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis.
Pica F; Volpi A; Gaziano R; Garaci E
Antivir Ther; 2010; 15(5):737-43. PubMed ID: 20710055
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]